Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” ...

Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

The finding means that building larger AI models for protein design, and feeding them more data, will produce predictably ...

With its patented, AI-powered, FDA-certified transmission X-ray technology, since 2007 NanoRay Biotech is radically transforming medical and industrial X-ray applications in Taiwan and aims to further ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging ...

By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers ...